{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:11:11Z","timestamp":1787731871485,"version":"build-2784847793"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jsbmb.2016.03.031","type":"journal-article","created":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T11:34:29Z","timestamp":1458732869000},"page":"64-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"PA","title":["Impact on CYP19A1 activity by mutations in NADPH cytochrome P450 oxidoreductase"],"prefix":"10.1016","volume":"165","author":[{"given":"Christa E.","family":"Fl\u00fcck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit V.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2016.03.031_bib0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pharmthera.2013.01.010","article-title":"NADPH P450 oxidoreductase: structure, function, and pathology of diseases","volume":"138","author":"Pandey","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fphar.2014.00103","article-title":"Pharmacogenomics of human P450 oxidoreductase","volume":"5","author":"Pandey","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0015","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM198511073131903","article-title":"Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia","volume":"313","author":"Peterson","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0020","series-title":"Genetic Steroid Disorders","first-page":"125","article-title":"Chapter 3H-P450 Oxidoreductase Deficiency (PORD)","author":"Fl\u00fcck","year":"2013"},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0025","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ng1300","article-title":"Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome","volume":"36","author":"Fl\u00fcck","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0030","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1081\/ERC-200044134","article-title":"P450 oxidoreductase deficiency: a new disorder of steroidogenesis affecting all microsomal P450 enzymes","volume":"30","author":"Pandey","year":"2004","journal-title":"Endocr. Res."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0035","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(04)16503-3","article-title":"Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study","volume":"363","author":"Arlt","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0040","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(04)17344-3","article-title":"P450 oxidoreductase deficiency","volume":"364","author":"Miller","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ajmg.a.30169","article-title":"Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome","volume":"128A","author":"Adachi","year":"2004","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0050","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1086\/429417","article-title":"Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis","volume":"76","author":"Huang","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0055","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ajhg.2011.06.009","article-title":"Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation","volume":"89","author":"Fl\u00fcck","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0060","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1210\/me.2007-0245","article-title":"Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase","volume":"21","author":"Pandey","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0065","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1210\/me.2007-0066","article-title":"Differential inhibition of CYP17A1 and CYP21A2 activities by the P450 oxidoreductase mutant A287P","volume":"21","author":"Dhir","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ando.2014.03.002","article-title":"Steroidogenesis of the testis\u2014new genes and pathways","volume":"75","author":"Fl\u00fcck","year":"2014","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mce.2014.03.008","article-title":"Characterization of a novel CYP19A1 (aromatase) R192H mutation causing virilization of a 46,XX newborn, undervirilization of the 46,XY brother, but no virilization of the mother during pregnancies","volume":"390","author":"Bouchoucha","year":"2014","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000321221","article-title":"Clinical and biochemical consequences of p450 oxidoreductase deficiency","volume":"20","author":"Fl\u00fcck","year":"2011","journal-title":"Endocr. Dev."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0090","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/dvdy.23892","article-title":"Backdoor pathway for dihydrotestosterone biosynthesis: implications for normal and abnormal human sex development","volume":"242","author":"Fukami","year":"2013","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0095","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.mce.2013.01.017","article-title":"Of marsupials and men: backdoor dihydrotestosterone synthesis in male sexual differentiation","volume":"371","author":"Biason-Lauber","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0100","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1210\/jc.2004-0810","article-title":"Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and\/or impaired steroidogenesis: molecular and clinical studies in 10 patients","volume":"90","author":"Fukami","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0105","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1073\/pnas.0711621105","article-title":"Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations","volume":"105","author":"Huang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0110","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/FPC.0b013e32832af5b7","article-title":"Nomenclature for alleles of the cytochrome P450 oxidoreductase gene","volume":"19","author":"Sim","year":"2009","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0115","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1210\/jc.2005-2460","article-title":"Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone","volume":"91","author":"Homma","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0120","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1203\/01.pdr.0000195825.31504.28","article-title":"Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and\/or aromatase deficiency: diagnostic value of urine steroid hormone analysis","volume":"59","author":"Fukami","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0125","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ajmg.a.31112","article-title":"POR R457H is a global founder mutation causing Antley-Bixler syndrome with autosomal recessive trait","volume":"140","author":"Adachi","year":"2006","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0130","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1042\/BST0341186","article-title":"Biochemical analysis of mutations in P450 oxidoreductase","volume":"34","author":"Pandey","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000134826","article-title":"P450 oxidoreductase deficiency\u2014a new form of congenital adrenal hyperplasia","volume":"13","author":"Fl\u00fcck","year":"2008","journal-title":"Endocr. Dev."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0140","doi-asserted-by":"crossref","DOI":"10.1111\/j.1472-8206.2007.00520.x","article-title":"Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase","volume":"21","author":"Fl\u00fcck","year":"2007","journal-title":"Fund. Clin. Pharmacol."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0145","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.mce.2010.02.024","article-title":"Restoration of mutant cytochrome P450 reductase activity by external flavin","volume":"321","author":"Nicolo","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.abb.2008.04.014","article-title":"Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley-Bixler syndrome variants of cytochrome P450 oxidoreductase","volume":"475","author":"Kranendonk","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0155","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/FPC.0b013e32830054ac","article-title":"Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19","volume":"18","author":"Agrawal","year":"2008","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0160","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2217\/pgs.09.7","article-title":"Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation","volume":"10","author":"Gomes","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0165","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1124\/dmd.111.042820","article-title":"Altered human CYP3A4 activity caused by Antley-Bixler syndrome-related variants of NADPH-cytochrome P450 oxidoreductase measured in a robust in vitro system","volume":"40","author":"Moutinho","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0170","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1124\/dmd.109.030445","article-title":"Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect","volume":"38","author":"Marohnic","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0175","doi-asserted-by":"crossref","first-page":"13486","DOI":"10.1073\/pnas.1106632108","article-title":"Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency","volume":"108","author":"Xia","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0180","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/clinids\/22.2.336","article-title":"Fluconazole-induced congenital anomalies in three infants","volume":"22","author":"Pursley","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0185","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/(SICI)1096-8628(19971031)72:3<253::AID-AJMG1>3.0.CO;2-S","article-title":"Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient","volume":"72","author":"Aleck","year":"1997","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1081\/ERC-120015045","article-title":"Assessing pregnancy risks of azole antifungals using a high throughput aromatase inhibition assay","volume":"28","author":"Kragie","year":"2002","journal-title":"Endocr. Res."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0195","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1210\/en.2005-0096","article-title":"Minireview: regulation of steroidogenesis by electron transfer","volume":"146","author":"Miller","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0200","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1210\/er.2008-0016","article-title":"History of aromatase: saga of an important biological mediator and therapeutic target","volume":"30","author":"Santen","year":"2009","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0205","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1530\/rep.0.1210685","article-title":"Mammalian aromatases","volume":"121","author":"Conley","year":"2001","journal-title":"Reproduction"},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0210","first-page":"4677","article-title":"Estrogen: consequences and implications of human mutations in synthesis and action","volume":"84","author":"Grumbach","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0215","first-page":"342","article-title":"Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis","volume":"15","author":"Simpson","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-2004-823023","article-title":"Aromatase: biologic relevance of tissue-specific expression","volume":"22","author":"Simpson","year":"2004","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0225","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-2002-35374","article-title":"The essential role of the aromatase\/P450arom","volume":"20","author":"Meinhardt","year":"2002","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0230","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1210\/jcem-72-3-560","article-title":"A new cause of female pseudohermaphroditism: placental aromatase deficiency","volume":"72","author":"Shozu","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0235","first-page":"126","article-title":"Aromatase research and its clinical significance","volume":"61","author":"Czajka-Oraniec","year":"2010","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0240","first-page":"321","article-title":"Genetic and clinical spectrum of aromatase deficiency in infancy, childhood and adolescence","volume":"72","author":"Belgorosky","year":"2009","journal-title":"Horm. Res."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0245","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1021\/bi400669h","article-title":"Structural basis for the functional roles of critical residues in human cytochrome p450 aromatase","volume":"52","author":"Lo","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0250","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.1021\/jm300930n","article-title":"Novel aromatase inhibitors by structure-guided design","volume":"55","author":"Ghosh","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0255","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jsbmb.2009.09.012","article-title":"X-ray structure of human aromatase reveals an androgen-specific active site","volume":"118","author":"Ghosh","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0260","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nature07614","article-title":"Structural basis for androgen specificity and oestrogen synthesis in human aromatase","volume":"457","author":"Ghosh","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0265","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.bbrc.2011.08.001","article-title":"Deletion of P399_E401 in NADPH cytochrome P450 oxidoreductase results in partial mixed oxidase deficiency","volume":"412","author":"Fl\u00fcck","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0270","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbrc.2010.09.035","article-title":"Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism","volume":"401","author":"Fl\u00fcck","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0275","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbrc.2010.08.072","article-title":"Altered heme catabolism by heme oxygenase-1 caused by mutations in human NADPH cytochrome P450 reductase","volume":"400","author":"Pandey","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0280","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1074\/jbc.M209527200","article-title":"Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17","volume":"278","author":"Pandey","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0285","doi-asserted-by":"crossref","first-page":"13265","DOI":"10.1074\/jbc.M414673200","article-title":"Regulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17","volume":"280","author":"Pandey","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0290","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-61737-967-3_7","article-title":"Efficient expression of human aromatase (CYP19) in E. coli","volume":"705","author":"Kagawa","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0295","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.steroids.2004.01.002","article-title":"Characterization of stable human aromatase expressed in E. coli","volume":"69","author":"Kagawa","year":"2004","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0300","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0039-128X(02)00168-X","article-title":"Expression of human aromatase (CYP19) in Escherichia coli by N-terminal replacement and induction of cold stress response","volume":"68","author":"Kagawa","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0305","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/abio.1998.2997","article-title":"A colorimetric assay for heme in biological samples using 96-well plates","volume":"268","author":"Pandey","year":"1999","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0310","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/S0021-9258(20)82244-3","article-title":"The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature","volume":"239","author":"Omura","year":"1964","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0315","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/dmd.112.048991","article-title":"NADPH-cytochrome P450 oxidoreductase: roles in physiology, pharmacology, and toxicology","volume":"41","author":"Riddick","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0320","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mce.2009.09.001","article-title":"Modeling of human P450 oxidoreductase structure by In silico mutagenesis and Md simulation","volume":"313","author":"Fl\u00fcck","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0325","doi-asserted-by":"crossref","first-page":"36628","DOI":"10.1074\/jbc.M109.054304","article-title":"Domain motion in cytochrome P450 reductase: conformational equilibria revealed by NMR and small-angle X-ray scattering","volume":"284","author":"Ellis","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2016.03.031_bib0330","doi-asserted-by":"crossref","first-page":"11374","DOI":"10.1074\/jbc.M807868200","article-title":"Structure and function of an NADPH-cytochrome P450 oxidoreductase in an open conformation capable of reducing cytochrome P450","volume":"284","author":"Hamdane","year":"2009","journal-title":"J. Biol. Chem."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076016300784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076016300784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:52:38Z","timestamp":1760745158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076016300784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":66,"alternative-id":["S0960076016300784"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2016.03.031","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact on CYP19A1 activity by mutations in NADPH cytochrome P450 oxidoreductase","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2016.03.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}